Celldex Therapeutics, Inc. — Director's Dealing 2013

Dec 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2013-12-06

Reporting Person: CATLIN AVERY W (Sr. VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-06	Common Stock	M	183333	$8.16	Acquired	197442	Direct
2013-12-06	Common Stock	S	183333	$24.50	Disposed	14109	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-06	Incentive Stock Option	$8.16	M	49016	Disposed	2015-03-07	Common Stock (49016)	Direct
2013-12-06	Non-Qualified Stock Option	$8.16	M	134317	Disposed	2015-03-07	Common Stock (134317)	Direct

Footnotes

F1: The option vested in four equal annual installments on March 7, 2009, March 7, 2010, March 7, 2011 and March 7,2012.

F2: The option vested in four annual installments. 33,580 shares on March 7, 2009 and 33,579 shares on March 7, 2010, March 7, 2011 and March 7, 2012.